Fresenius Medical Care AG & Co. KGaA $FMS Shares Purchased by Pzena Investment Management LLC

Pzena Investment Management LLC raised its position in Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) by 2.0% during the 1st quarter, Holdings Channel reports. The firm owned 15,052,822 shares of the company’s stock after acquiring an additional 299,986 shares during the quarter. Fresenius Medical Care AG & Co. KGaA comprises about 1.1% of Pzena Investment Management LLC’s holdings, making the stock its 28th biggest position. Pzena Investment Management LLC’s holdings in Fresenius Medical Care AG & Co. KGaA were worth $339,592,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in FMS. AQR Capital Management LLC boosted its position in shares of Fresenius Medical Care AG & Co. KGaA by 14.2% in the 1st quarter. AQR Capital Management LLC now owns 14,297 shares of the company’s stock worth $356,000 after buying an additional 1,777 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in Fresenius Medical Care AG & Co. KGaA by 160.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 37,610 shares of the company’s stock valued at $1,075,000 after acquiring an additional 23,163 shares in the last quarter. American Century Companies Inc. raised its position in Fresenius Medical Care AG & Co. KGaA by 21.3% during the second quarter. American Century Companies Inc. now owns 29,173 shares of the company’s stock worth $833,000 after acquiring an additional 5,127 shares during the last quarter. Russell Investments Group Ltd. raised its position in Fresenius Medical Care AG & Co. KGaA by 21.3% during the second quarter. Russell Investments Group Ltd. now owns 5,096 shares of the company’s stock worth $146,000 after acquiring an additional 896 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 141.8% in the second quarter. EverSource Wealth Advisors LLC now owns 2,906 shares of the company’s stock valued at $83,000 after purchasing an additional 1,704 shares in the last quarter. Hedge funds and other institutional investors own 8.37% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Zacks Research lowered shares of Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a research report on Wednesday, May 27th. Jefferies Financial Group upgraded Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a research report on Friday, May 8th. Weiss Ratings lowered Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, May 7th. Morgan Stanley reiterated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Wednesday, May 6th. Finally, Wall Street Zen downgraded Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Four equities research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Strong Sell” and a consensus target price of $28.00.

Fresenius Medical Care AG & Co. KGaA Price Performance

Fresenius Medical Care AG & Co. KGaA stock opened at $22.88 on Thursday. Fresenius Medical Care AG & Co. KGaA has a 12-month low of $20.02 and a 12-month high of $28.62. The stock has a market capitalization of $12.36 billion, a P/E ratio of 12.04, a P/E/G ratio of 4.08 and a beta of 0.80. The firm’s 50-day moving average is $22.31 and its two-hundred day moving average is $22.83. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.20 and a quick ratio of 0.86.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last released its earnings results on Tuesday, March 31st. The company reported $1.05 EPS for the quarter. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. The firm had revenue of $5.34 billion during the quarter. Equities analysts predict that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The firm also recently announced an annual dividend, which was paid on Monday, June 8th. Investors of record on Friday, May 22nd were paid a $0.8716 dividend. The ex-dividend date was Friday, May 22nd. This is an increase from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. This represents a yield of 402.0%. Fresenius Medical Care AG & Co. KGaA’s payout ratio is currently 31.58%.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.